Clinical-stage biotechnology company developing a therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer.

Sectors
Healthcare
Life Sciences
First Invested
2009
Public/PIPES
Company Status
NASDAQ: INFI
Associated Team
Paul Walker